| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMM | Common Stock | Options Exercise | $268,561 | +2,111 | +317% | $127.22 | 2,777 | 01 Nov 2024 | Direct | F1 |
| transaction | MMM | Common Stock | Tax liability | $82,184 | -646 | -23% | $127.22 | 2,131 | 01 Nov 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMM | Restricted Stock Units | Options Exercise | $0 | -2,111 | -100% | $0.000000 | 0 | 01 Nov 2024 | Common Stock | 2,111 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of 3M common stock. |
| F3 | The restricted stock units vest three years from the grant date. |